Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Lisuride in Early Parkinson's Disease
2006-003732-30Phase 3Active
- Sponsor
- Axxonis Pharma AG
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) comparing Transdermal lisuride with Placebo (2 arms). Primary endpoint: Combined UPDRS II+III score change. Started Nov 2006; status: active.
02
Drugs
lisuride
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2006-003732-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003732-30.